| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Medical Officer | SVP, Chief Development Officer
1 company
Simonson Steven is a SVP, Chief Medical Officer at WINT. Recent filings cover 4 purchases and 0 sales.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2022 | WINT Windtree Therapeutics Inc /de/ | SVP, Chief Medical Officer | Buy | 5,000 | $1.00 | $4,999.00 | +6.4% | |
| Mar 25, 2021 | WINT Windtree Therapeutics Inc /de/ | SVP, Chief Medical Officer | Buy | 1,500 | $3.25 | $4,875.00 | +13.9% | |
| May 22, 2020 | WINT Windtree Therapeutics Inc /de/ | SVP, Chief Medical Officer | Buy | 517 | $7.25 | $3,748.25 | +5.0% | |
| Jul 22, 2015 | WINT Windtree Therapeutics Inc /de/ | SVP, Chief Development Officer | Buy | 16,667 | $0.00 | - | +83,335% |